Seeing Is Believing
Currently out of the existing stock ratings of Dane Leone, 106 are a BUY (82.81%), 21 are a HOLD (16.41%), 1 are a SELL (0.78%).
Analyst Dane Leone works at RAYMOND JAMES with a stock forecast success ratio of 59.27% fulfilled within 198.89 days on average.
Dane Leone’s has documented 226 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RGNX, Regenxbio at 21-Feb-2024.
Analyst best performing recommendations are on NKTX (NKARTA ).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) at 12/28/2021. The price target of $17 was fulfilled within 6 days with a profit of $3.57 (26.58%) receiving and performance score of 44.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$-6.19 (-60.75%)
2
2 months 20 days ago
4/4 (100%)
$1.5 (60.00%)
279
Buy
6
$4.05 (207.69%)
4
7 months 21 days ago
4/7 (57.14%)
$4.22 (237.08%)
196
Buy
4
$-6.19 (-60.75%)
2
8 months 15 days ago
4/4 (100%)
$2.11 (111.64%)
432
Hold
3
$-7.19 (-70.56%)
6
1 years 5 months 15 days ago
3/4 (75%)
$2.23 (289.61%)
528
Hold
2
$-8.19 (-80.37%)
5
2 years 9 months 3 days ago
3/3 (100%)
$-0.36 (-15.25%)
397
Which stock is Dane Leone is most bullish on?
Which stock is Dane Leone is most reserved on?
What Year was the first public recommendation made by Dane Leone?